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ABSTRACT 
Endogenous and succinic dehydrogenase activity was demonstrated in the living cells of 
normal human blood and bone marrow using a  buffered nitro BT-succinate incubating 
solution. With this technique dchydrogenase activity was localized primarily in the granular 
leukocytes  and  the  sites  of cnzymatic activity appcared  to  be  non-mitochondrial. The 
addition of a non-ionic surface  active agent to thc incubating solution resulted in marked 
differences in the  cellular and intracellular localization of dehydrogenase activity. With 
this method it was possible  to demonstrate dehydrogenase activity in the mitochondria of 
most of the formed elements of the blood and bone marrow, including  developing granulo- 
cytes  and  erythroid  cells,  agranulocytes,  and  blood  platelets.  Mature  erythrocytes  also 
exhibited a  minimal dehydrogenase reaction with this procedure. This investigation indi- 
cated that in order adequately to demonstrate and evaluate dehydrogenase activity in the 
cells of the blood and bone marrow it was necessary to have increased cellular and mito- 
chondrial permeability, as well as partially viable cells with an intact dehydrogenase system. 
Few  histochemical  studies  have  been  reported 
concerning  the  localization  of  dehydrogenase 
activity in the cells of the blood and bone marrow 
(1,  8,  14,  15,  17). Wachstein's studies  (14,  15) 
indicated the  presence of dehydrogenase activity 
in many of the  cellular elements of normal and 
abnormal  blood,  bone  marrow,  and  lymphatic 
tissue,  as  well  as  in  exudates,  by  the  use  of  a 
buffered  neotetrazolium  (2,2'-(p-diphenylene)- 
bis(3,5-diphenyl) tetrazolium chloride) incubating 
medium. These studies indicated further that the 
reaction was improved by the addition of sodium 
succinate or  various activators to  the  incubating 
solution. Wachstein reported  (14)  the presence of 
dehydrogenase  activity in  62  to  84  per  cent of 
the granulocytes of the blood while only a  small 
number  of  the  circulating  lymphocytes  and 
monocytes exhibited enzyme activity. In contrast 
with the lymphocytes of the blood nearly half of 
the lymphocytic cells  present in lymphatic tissue 
exhibited  dehydrogenase  activity  (14).  Other 
workers (3, 4,  12)  have successfully demonstrated 
succinic dehydrogenase activity in the lymphocytic 
cells of lymphatic tissue employing various tetra- 
zolium  salts.  The  degree  of  reactivity  of  the 
lymphocytes of both blood (1,  14)  and lymphatic 
tissue  (3,  4)  has been reported  to vary in certain 
hematological diseases. 
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61 Wachstein  (14,  15)  observed  dehydrogenase 
activity  in  developing granulocytes  (myelocytes) 
in human bone marrow but was unable to demon- 
strate activity in  the more immature myeloblasts. 
He  noted  the  apparent  inverse  relationship 
between  the  presence  of  mitochondria  and 
histochemically demonstrable  dehydrogenase ac- 
tivity  in  developing  granulocytes  and  suggested 
(14)  that  this  observation  might  be  related  to 
differences in  aerobic  and  anaerobic  metabolism 
reported in leukocytes (2). 
Recently, De  Souza and  Kothare  (8)  localized 
succinic dehydrogenase activity in  the  cytoplasm 
of human granulocytes using the nitro BT  (2,2'- 
di  -  p  -  nitrophenyl  -  5,5'  -  diphenyl  -  3~3'  - 
(3,3'-dimethoxy-4,4'-biphenylene) ditetrazolium 
chloride)  salt.  These  investigators  noted  the 
presence  of  endogenous  dehydrogenase  activity 
in  the  granulocytes but  obtained  a  more  intense 
reaction  following  the  addition  of  succinate  to 
the medium. Yakaitis (17,  18) using an incubating 
solution  consisting  of  INT  (2-(p-iodophenyl)-3- 
(p-nitrophenyl)-5-phenyl  tetrazolium  chloride) 
dissolved  in  N, N-dimethyl  formamide  and 
phosphate buffer,  pH  7.5,  and  in  the  absence of 
succinate or other substrates noted that the leuko- 
cytes  of  infant  and  old  mice  exhibited  less  de- 
hydrogenase  activity  than  those  of  young  adult 
mice.  In  addition  leukocytes  of  healthy  adult 
mice  of  the  AKR-susceptible  strain  exhibited 
a  greater  dehydrogenase  reaction  than  the 
leukocytes from two resistant strains. 
It was the purpose of this investigation to define 
the  localization of dehydrogenase activity in  the 
cells  of normal  human  blood  and  bone  marrow 
employing nitro BT  as  the  tetrazolium salt  (12). 
Two  methods  will  be  described  and  differences 
obtained  in  enzymatic  localization  will  be  dis- 
cussed. 
MATERIALS  AND  METHODS 
Method A 
Vital  preparations  were  prepared  in  the  following 
manner. A small drop of fresh blood was mixed on a 
coverslip with a  drop of incubating solution consist- 
ing of 2.6 mg./ml, of sodium succinate and 1 mg./ml. 
of nitro  BT  ~ in  0.1  M Sorensen's phosphate buffer, 
1 Dajac Laboratories, Philadelphia. A highly purified 
sample of nitro BT prepared by and supplied through 
the courtesy of Dr.  A.  M.  Seligman also  was tested. 
Both  preparations  yielded  similar  results  in  these 
studies. 
pH  7.4.  The coverslip was then inverted on  a  slide 
and  the preparation examined with the bright-field 
and/or  phase  contrast  microscope.  Blue-purple 
deposits  of  formazan,  indicative  of  sites  of  dehy- 
drogenase activity, began to appear after 10 minutes 
and a maximal reaction was obtained between 30 and 
60  minutes.  Optimal  incubation  time  was  about 
30  minutes.  Longer  periods  of  incubation  usually 
resulted in the growth of the intracellular formazan 
deposits and a  loss of cellular motility and viability. 
Controls were made in the same manner except that 
succinate  was  omitted  or  the  enzyme  inactivated 
with heat,  iodoacetic acid,  and  ethyl  maleimide. 
Comparable  studies were performed in  test  tubes 
using  larger  quantities  of blood  (heparinized)  and 
incubating solutions in  order  to  compare the effect 
of various  buffers and  suspending solutions,  as  well 
as the effect of enzymatic inactivation on the dehydro- 
genase reaction and sites  of intraeellular localization. 
Either  vital  films  or  air-dried  films  prepared  from 
the  above  mixture  of blood  and  media  fixed  with 
formalin  vapor  and  mounted  with  glycerin  were 
prepared  and  examined  microscopically. 0.1  ~l  tris 
buffer, pH  7.4,  caused slight cellular damage; albu- 
min  (6  per  cent)  and  polyvinylpyrrolidone  (6  and 
7.5  per  cent)  resulted  in  marked  clumping  and 
subsequent  death  and  destruction  of  granulocytes 
and  platelets.  Sorensen's phosphate buffer,  pH  7.4, 
was  considered  the  best  suspending  medium  and 
gave  excellent preservation of cellular  morphology, 
viability, and motility; produced no cellular clump- 
ing  and  gave  reproducible histochemieal reactions. 
Heat,  iodoaeetic  acid,  and  ethyl  maleimide  com- 
pletely  inhibited  the  tetrazolium  reaction. 
Method B 
This  method  differed from  Method  A  only  in  the 
addition  of a  non-ionic surface active  agent  to  the 
incubating  solution.  This  agent  served  to  increase 
cellular  permeability  permitting  the  access  of  the 
tetrazolium  salt  and/or  substrate  to  the  cell.  The 
incubating  solution  consisted  of  2.6  mg./ml,  of 
sodium succinate,  1  mg./ml,  of nitro  BT  in  0.1  M 
Sorensen's phosphate buffer, pH 7.4, and  1 drop/ml. 
of renex 20. 2 Maximal reactions developed between 
30  and  60  minutes.  Since  these were  accompanied 
by cellular damage, constant microscopic observation 
of the preparation was desirable. Control procedures 
included  omission  of  succinate  and/or  the  surface 
active  agent,  as  well  as  enzymatic  inactivation  by 
heat,  iodoacetic  acid,  and  ethyl  maleimide. 
RESULTS 
When  Method  A  was  used  nearly  all  the 
2 Renex 20 was obtained from the Atlas Powder Co., 
Wilmington. 
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dehydrogenase  reaction  even  in  the  absence  of 
succinate  (endogenous  dehydrogenase  activity), 
but these cells were somewhat more reactive when 
succinate  was  used  in  the  incubating solution. 
The  localization  and  distribution  of  enzyme 
activity indicated by the  deposition of formazan 
showed pronounced variations in the neutrophils. 
Usually, the first  appearance of formazan within 
the neutrophil was in the region of the cytocentrum 
where  it  showed  as  small  blue-purple granules, 
as  small  rod-like  deposits,  or  occasionally as  a 
non-particulate  diffuse  blue-purple  coloration. 
After  15  to  30  minutes'  incubation  formazan 
deposits  appeared  as  moderate-sized granules or 
crystal-like  deposits  in  some  of  the  neutrophils 
(Figs.  1 and 2).  The ameboid activity of the cells 
permitted  the  formazan  deposits  to  assume  a 
random  distribution  throughout  the  cytoplasm. 
Many neutrophils showed  a  blue-purple colora- 
tion localized in their specific (neutrophil) granules 
(Fig.  3).  In some  instances, all of the  neutrophil 
granules were colored, while in other cells only a 
variable number of these  granules were  colored. 
In addition, some neutrophils exhibited a diffuse, 
non-particulate  blue-purple  coloration  of  their 
cytoplasm (hyaloplasm) with little or no particu- 
late  formazan  localization  in  the  neutrophil 
granules or hyaloplasm (Fig.  4). 
Eosinophils usually were reactive and exhibited 
a  diffuse,  non-granular blue-purple coloration of 
their  cytoplasm  (Fig.  5)  which  made  its  first 
appearance  in  the  region  of  their  prominent 
~ytocentrum.  Few  eosinophil granules  exhibited 
dehydrogenase activity. Although monocytes were 
almost uniformly non-reactive for  dehydrogenase 
activity  with  this  technique,  a  few  monocytes 
exhibited  a  blue-purple deposition  of  formazan 
around the cytocentrum (Fig. 6).  These deposits 
were shown to be localized in the so-called segrega- 
tion vacuoles that can be seen in monocytes stained 
by the  supravital (neutral red  and Janus green) 
technique,  as  well  as  in  unstained  vital  films 
examined  with  the  phase  microscope.  Mito- 
chondria were non-reactive. 
Only  extremely  rarely  did  lymphocytes  ex- 
hibit a positive reaction with the nitro BT (Method 
A)  reaction.  In these  instances, the  lymphocytes 
appeared  slightly damaged  morphologically and 
the formazan coloration was  localized in some  of 
their  mitochondria  and  in  their  "neutral  red" 
vacuoles.  Platelets  and  erythrocytes  were  con- 
sistently non-reactive with this technique. 
In  the  bone  marrow,  a  few  neutrophil  and 
eosinophil myelocytes (Fig.  7) exhibited a positive 
dehydrogenase  reaction  with  the  deposition  of 
formazan  localized  near  the  cytocentrum.  This 
reactivity appeared  both as  a  local coloration of 
the  specific  granules and  as  a  diffuse  coloration 
of  the  cytoplasm  (hyaloplasm)  in  this  region. 
Developing  erythroid  elements  occasionally 
showed  a  blue-purple staining of a  small number 
of their  cytoplasmic vacuoles which were  shown 
to correspond to the neutral red staining vacuoles 
seen  in  routine  supravital  films.  Mitochondria, 
identified by Janus green B and phase microscopy, 
were  consistently unstained  in  both  developing 
erythroid and myeloid elements. Megakaryocytes 
were  usually  non-reactive  but  occasionally  ex- 
hibited a minimal reaction in the form of a finely 
granular  deposition  of  formazan  in  their  cyto- 
plasm. Only rarely did plasma cells yield a positive 
dehydrogenase  reaction  and  in  these  instances 
activity was localized to their cytoplasmic vacuoles 
rather than to their mitochondria. 
About two-thirds of the lymphocytes present in 
normal human lymph nodes,  and  in  nodes  ob- 
tained  from  rats,  exhibited  a  positive  dehydro- 
genase reaction with sites of activity localized in 
their  mitochondria.  Lymphoblasts were  positive 
but less reactive than the more mature, medium- 
sized,  and small lymphocytes. Many lymphocytes 
were damaged during the preparation of the cell 
suspensions,  but lymphocytes exhibiting a I~ositive 
dehydrogenase  reaction  showed  only  minimal 
signs  of morphologic damage. Lymphocytes with 
marked  cellular alterations or  damage,  in  most 
instances, failed to react following this technique. 
Because  of the  possibility that  the  tetrazolium 
salt and/or succinate was unable to pass  through 
the  plasma  and/or  mitochondrial  membranes, 
a  non-ionic surface  active  agent  was  added  to 
the  incubating  solution  in  order  to  increase 
membrane  permeability  (Method  B).  Freezing 
and thawing was attempted initially as a method 
to  alter  cellular  permeability but  proved  to  be 
very  destructive  with  immediate  cellular  frag- 
mentation  and  dissolution.  With  the  surface 
active  agent-nitro  BT  technique  (Method  B) 
it  was  possible  to  stain  the  mitochondria  in 
cellular elements of the blood and bone marrow. 
When Method B was employed, the lymphocytes 
of the  blood exhibited a  rather  strong formazan 
production which was  sharply localized  in their 
mitochondria  (Figs.  8,  9).  The  lymphocytes 
exhibited  only  minimal  signs  of  morphologic 
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the  lymphocytes  and  their  mitochondria  soon 
became  swollen  indicating  cellular  damage. 
Monocytes  showed  a  positive  dehydrogenase 
reaction  with  this technique  and  the  blue-purple 
coloration  appeared  to  be  localized  in  both their 
mitochondria  and,  perhaps  also,  in some  of their 
cytoplasmic  vacuoles.  Blood  platelets  exhibited 
several  fine  formazan  deposits  which  possibly 
corresponded  to  their  mitochondria.  Mature 
erythrocytes  also  were  capable  of  exhibiting  a 
positive  dehydrogenase  reaction  with  the  forma- 
tion  of  three  or  four  small  formazan  deposits 
within  the  cell.  Formazan  deposits did  not  make 
their  appearance  until  immediately  prior  to 
erythrocyte  hemolysis.  In  most  preparations, 
granulocytes  were  rounded,  lacked  ameboid 
activity  and  exhibited  marked  Brownian  move- 
ment which indicated the loss of cellular viability. 
These  cells  were  non-reactive  for  dehydrogenase 
activity  in  contrast  with  their  strong  reactivity 
and viability in preparations lacking the surface-- 
active  agent.  Endogenous  dehydrogenase  activity 
was  observed  in  the  mitochondria of most  of the 
FIGURE 1 
Neutrophil  containing  several  dark  cytoplasmic  deposits  of  formazan.  Nitro  BT- 
succinate in Sorensen's phosphate buffer (Method A).  15 minute incubation.  X  1250. 
FIGURE 
A group of neutrophils. Neutrophil (A) is non-reactive; neutrophil (B) shows a number 
of cytoplasmic  deposits  of formazan;  neutrophil  (C)  exhibits a  strong reaction  with 
both  formazan  aggregates  and  crystal-like  deposits.  Nitro  BT-succinate  in  6  per 
cent  polyvinylpyrrolidone.  60  minute  incubation.  X  1250. 
FIGURE 3 
Ncutrophil  (A)  is  non-reactive, neutrophil  (B)  shows  a  positive dehydrogenase reac- 
tion  localized  in  the  neutrophil  granules.  Nitro  BT-succinate  in  6  per  cent  human 
albumin.  30 minute incubation.  X  1250. 
FIGURE 4 
Two  neutrophils showing  a  positive dehydrogenase  reaction  in  the  hyaloplasm  and 
near the cell membrane. The reaction appears essentially non-particulate,  Nitro BT- 
succinate in Sorensen's phosphate buffer (Method A). 30 minute incubation.  X  1250. 
FIGURE 5 
Eosinophil showing a  diffuse non-particulate dehydrogenase reaction localized in the 
hyaloplasm.  Nitro  BT-succinate  in  Sorensen's  phosphate  buffer  (Method  A).  30 
minute  incubation.  X  1250. 
FIGURI~ 6 
Monocyte with formazan deposition localized in the region of the cytocentrum.  Nitro 
BT-succinate in Sorcnsen's phosphate buffer  (Method A).  Phase contrast microscope. 
45  minute incubation.  X  1250. 
FIGURE 7 
Eosinophilic myelocyte  with a  diffuse non-particulate dehydrogenase reaction in  the 
prominent  cytocentrurn  and  also  a  coloration  of  the  eosinophil  granules  near  this 
region.  Nitro  BT-succinate  in  Sorensen's  phosphate  buffer  (Method  A).  30  minute 
incubation.  X  1250. 
FIGtTRES 8 and 9 
Lymphocytes  exhibiting  a  positive  dehydrogenase  reaction  localized  to  their  mito- 
chondria.  Two  small  formazan  granules  may  be seen  in  the  erythrocyte  (A).  Nitro 
BT-succinate-renex 20 in Sorensen's phosphate buffer (Method B). 30 minute incuba- 
tion.  X  1250. 
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dition  of  succinate  to  the  incubating  solution 
definitely  increased  mitochondrial  reactivity. 
Enzymatic inactivation by heat,  iodoacetic acid, 
and  ethyl  maleimide  inhibited  the  tetrazolium 
reaction. 
DISCUSSION 
The  demonstration of  endogenous and  succinic 
dehydrogenase  activity in  the  intact living cells 
of the blood and bone marrow obtained with the 
nitro  BT-succinate  (Method  A)  technique  cor- 
respond  to  the  results reported  by other  investi- 
gators employing either nitro BT (8,  17) or other 
tetrazoles  (14,  15)  in  their  incubating solutions. 
Our observations indicate that, in most instances, 
sites  of  dehydrogenase  activity  shown  by  the 
reduction of the tetrazole are non-mitochondrial; 
e.g.,  cytoplasmic  vacuoles,  specific  granules,  or 
the diffuse  hyaloplasm of the granular leukocytes. 
It  seemed  unlikely  that  the  number  of  mito- 
chondria  present  in  the  mature  granulocytes 
could account for  either  the  strong reactivity or 
the intracellular distribution of formazan observed 
in  these  cells.  Except  in certain instances when 
the  cells  were  morphologically  damaged,  the 
mitochondria  observed  in  the  agranulocytes, 
developing  myeloid,  and  erythroid  cells  were 
histochemically  negative  for  dehydrogenase  ac= 
tivity (Method A). 
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brane  of the  mitochondrion  acts  as  a  barrier  for 
the  penetration  of the  tetrazolium  salts  and  that 
this  membrane  must  be  damaged  in  order  to 
obtain  adequate  histochemical  reactions  with 
nitro BT for the oxidative enzymes residing in the 
mitochondrion  (13).  Increased  cellular  and 
mitochondrial  permeability  was  achieved  in  our 
studies  by  the  addition  of  a  non-ionic  surface- 
active  agent  to  the  incubating  solution  (Method 
B).  In such  preparation  the mitochondria  present 
in most of the  cellular elements of the  blood  and 
bone  marrow  consistently  exhibited  a  positive 
dehydrogenase  reaction.  In  addition  to  the 
agranulocytes,  developing  granulocytes,  and 
erythroid  cells,  blood  platelets and  mature  eryth- 
rocytes  also  exhibited  a  positive  dehydrogenase 
reaction  with  this  technique.  However,  gran- 
ulocytes  exposed  to  the  surface-active  agent- 
tetrazolium  reaction  exhibited  both  morphologic 
alteration  and  loss  of motility and  failed  to  show 
dehydrogenase  activity in  contrast  with  prepara- 
tions  lacking  this  agent.  These  observations 
suggest  that  in  order  to  demonstrate  successfully 
dehydrogenase  activity  in  the  cells  of  the  blood 
and  bone  marrow  with  the  tetrazolium  methods, 
it  is  necessary  to  have  increased  cellular  and/or 
mitochondrial  permeability  and  partially  viable 
cells  with  an  essentially  intact  dehydrogenase 
system. 
The  localization  of  histochemically  demon- 
strable  dehydrogenase  activity  obtained  in  these 
studies,  using  both  of  the  tetrazolium  methods 
described,  conforms  with  biochemical  evidence 
that  has  established  the  presence  of Krebs  cycle 
activity  in  human  teukocytes  (5,  11,  16).  Small 
amounts of dehydrogenase  activity have also been 
demonstrated  biochemically  in  mature  eryth- 
rocytes  (7).  Succinic  dehydrogenase,  alpha 
glycerophosphate dehydrogenase  activity (10,  16), 
and  endogenous  oxygen  consumption  appear 
high  in  both  leukocytes  and  blood  platelets  (16). 
The  addition  of  intermediate  Krebs  cycle  sub- 
strates,  in  most  instances,  produces  a  greater 
metabolic  response  in  damaged  or  broken  cells 
than  in intact  cells and  appears  to  be dependent 
upon  cellular  permeability  (11).  Although  the 
oxidative  activity  of  the  leukocytes  may  not  be 
quantitatively  similar  to  that  of  other  tissues,  a 
final  common  pathway  for  oxidation  is  qualita- 
tively similar to  that  present in other tissues  (11). 
Controlled  histochemical  studies  indicate  that 
the  formazan  deposition  noted  in  the  cells of the 
blood  and  bone  marrow  with  both  Methods  A 
and  B  is  the  result  of  dehydrogenase  activity 
since  it  is  possible  to  inhibit  cellular  reactivity 
with  heat,  iodoacetic acid,  and  ethyl  maleimide. 
The  non-mitochondrial  localization  of  dehy- 
drogenase  activity  noted  in  these  studies  may 
perhaps be related  to the results from biochemical 
studies  of  homogenates,  which  have  suggested 
that  the  dehydrogenase  and  oxidative  enzymes 
present  in  other  cells  and  tissues  of  the  body  in 
some instances may be extramitochondrial  as well 
as localized within the mitochondrion  (6,  9). 
Because  of  the  presence  of  endogenous  de- 
hydrogenase  activity in  certain  of the  leukocytes 
of  the  blood  and  bone  marrow,  further  studies 
designed  to  identify  various  members  of  the 
oxidative  pathway  (e.g.  by  employing  various 
substrates)  (13)  may  be  difficult  to  interpret 
without  marked  differences in  cellular  reactivity, 
localization,  or  adequate  methods  to  destroy 
endogenous  dehydrogenase  activity with minimal 
impairment  of  cellular  integrity.  This  study 
indicates  that  to  evaluate  adequately  dehydro- 
genase activity in the cellular elements of the blood 
and bone marrow, both dehydrogenase techniques 
described  herein should  be employed. Less drastic 
methods  should  be  sought  to  reduce  cellular 
damage  resulting  from  the  action  of the  surface- 
active  agent  and  further  to  ensure  adequate 
cellular  preservation  and  better  enzymatic  re- 
activity and localization. 
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